Journal article
Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors
- Abstract:
- BACKGROUND AND PURPOSE: Adenophostin A (AdA) is a potent agonist of inositol 1,4,5-trisphosphate receptors (IP 3R). AdA shares with IP 3 the essential features of all IP 3R agonists, namely structures equivalent to the 4,5-bisphosphate and 6-hydroxyl of IP 3, but the basis of its increased affinity is unclear. Hitherto, the 2'-phosphate of AdA has been thought to provide a supra-optimal mimic of the 1-phosphate of IP 3. EXPERIMENTAL APPROACH: We examined the structural determinants of AdA binding to type 1 IP 3R (IP 3R1). Chemical synthesis and mutational analysis of IP 3R1 were combined with 3H-IP 3 binding to full-length IP 3R1 and its N-terminal fragments, and Ca 2+ release assays from recombinant IP 3R1 expressed in DT40 cells. KEY RESULTS: Adenophostin A is at least 12-fold more potent than IP 3 in functional assays, and the IP 3-binding core (IBC, residues 224-604 of IP 3R1) is sufficient for this high-affinity binding of AdA. Removal of the 2'-phosphate from AdA (to give 2'-dephospho-AdA) had significantly lesser effects on its affinity for the IBC than did removal of the 1-phosphate from IP 3 (to give inositol 4,5-bisphosphate). Mutation of the only residue (R568) that interacts directly with the 1-phosphate of IP 3 decreased similarly (by -30-fold) the affinity for IP 3 and AdA, but mutating R504, which has been proposed to form a cation-Π interaction with the adenine of AdA, more profoundly reduced the affinity of IP 3R for AdA (353-fold) than for IP 3 (13-fold). CONCLUSIONS AND IMPLICATIONS: The 2'-phosphate of AdA is not a major determinant of its high affinity. R504 in the receptor, most likely via a cation-Π interaction, contributes specifically to AdA binding.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.7MB, Terms of use)
-
- Publisher copy:
- 10.1111/j.1476-5381.2010.00947.x
Authors
- Publisher:
- Wiley
- Journal:
- British Journal of Pharmacology More from this journal
- Volume:
- 161
- Issue:
- 5
- Pages:
- 1070–1085
- Publication date:
- 2010-07-02
- Acceptance date:
- 2010-06-07
- DOI:
- ISSN:
-
0007-1188, 1476-5381
- Pmid:
-
20977457
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:640325
- UUID:
-
uuid:b1b4edeb-5b5e-4ffe-ac4a-1a4f5fb9aad4
- Local pid:
-
pubs:640325
- Source identifiers:
-
640325
- Deposit date:
-
2016-08-24
- ARK identifier:
Terms of use
- Copyright holder:
- The British Pharmacological Society
- Copyright date:
- 2010
- Notes:
- Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
If you are the owner of this record, you can report an update to it here: Report update to this record